Felypressin structure
|
Common Name | Felypressin | ||
---|---|---|---|---|
CAS Number | 56-59-7 | Molecular Weight | 1040.219 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 1571.3±65.0 °C at 760 mmHg | |
Molecular Formula | C46H65N13O11S2 | Melting Point | 254-257 °C | |
MSDS | Chinese USA | Flash Point | 904.1±34.3 °C |
Use of FelypressinFelypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As.target: Vasopressin 1 agonist;Felypressin is a synthetic hormone of the posterior pituitary lobe characterized by vasoconstrictor properties that is widely used in dental procedures.Felypressin has been widely added to local anesthetic solutions to increase the duration of the anesthetic effect and reduce the risk of toxicity during dental procedures. |
Name | felypressin |
---|---|
Synonym | More Synonyms |
Description | Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As.target: Vasopressin 1 agonist;Felypressin is a synthetic hormone of the posterior pituitary lobe characterized by vasoconstrictor properties that is widely used in dental procedures.Felypressin has been widely added to local anesthetic solutions to increase the duration of the anesthetic effect and reduce the risk of toxicity during dental procedures. |
---|---|
Related Catalog | |
References |
[2]. Cecanho R et al. Cardiovascular effects of felypressin. Anesth Prog. 2006 Winter;53(4):119-25. |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 1571.3±65.0 °C at 760 mmHg |
Melting Point | 254-257 °C |
Molecular Formula | C46H65N13O11S2 |
Molecular Weight | 1040.219 |
Flash Point | 904.1±34.3 °C |
Exact Mass | 1039.436768 |
PSA | 455.92000 |
LogP | -5.00 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.574 |
Hazard Codes | Xi |
---|---|
Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . |
Safety Phrases | S24/25 |
RIDADR | NONH for all modes of transport |
Ex vivo correlation of the permeability of metoprolol across human and porcine buccal mucosa.
J. Pharm. Sci. 103(7) , 2053-61, (2014) The pH partition theory proposes a correlation between fraction of unionized drug substance and permeability. The aim of this study was to compare the permeability of metoprolol and mannitol in ex viv... |
|
Intraoperative local anaesthesia for reduction of postoperative pain following general anaesthesia for dental treatment in children and adolescents.
Cochrane Database Syst. Rev. 12 , CD009742, (2014) Whilst carrying out dental procedures under general anaesthesia (GA), practitioners routinely give local anaesthetics (LA) intraoperatively to children. Local anaesthetics are used to help manage post... |
|
Octopus, which owns the most advanced brain in invertebrates, has two members of vasopressin/oxytocin superfamily as in vertebrates.
Regul. Pept. 115(2) , 139-49, (2003) A novel member of the vasopressin/oxytocin superfamily, octopressin (OP), has been isolated from Octopus vulgaris. Since another peptide of this superfamily, cephalotocin (CT), was isolated from the s... |
(2-L-Phenylalanine)-8-lysinevasopressin |
Glycinamide, 1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-6,9,12,15,18-pentaoxo-13,16-bis(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-yl]carbonyl]-L-prolyl-L-lysyl- |
Felypressine |
M.W. 1040.22 C46H65N13O11S2 |
Felypressin Acetate |
2-(Phenylalanine)-8-lysine vasopressin |
felypressin |
[PHE2,LYS8]-VASOPRESSIN |
2-(L-Phenylalanine)-8-L-lysinevasopressin |
Octapressin |
MFCD00868221 |
PLV-2 |
2-(phenylalanine)-8-lyine vasopression |
Phelypressin |
L-Cysteinyl-L-phenylalanyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1®6)disulfide |
EINECS 200-282-7 |
1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-lysylglycinamide |